M&H BIO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
M&H BIO
Largest movements
- Cash -€43,551
down €43,551 (-99.1%), from €43,942 to €391
mainly Receivables within one year (-€33,950) and Stocks and contracts (-€22,485)
- Receivables within one year +€33,950
new in 2024: €33,950
of which Trade receivables: +€23,950
- Stocks and contracts +€22,485
new in 2024: €22,485
- Tax, wage and social debts +€5,813
up €5,813 (+30.9%), from €18,809 to €24,621
of which Taxes: +€4,169
- Advances received +€4,779
new in 2024: €4,779
- Trade debts -€4,205
no longer reported in 2024 (was €4,205)
- Profit (loss) carried forward +€3,871
up €3,871 (+18.5%), from €20,928 to €24,799
- Other debts +€2,627
new in 2024: €2,627
- Gross operating margin -€43,623
down €43,623 (-63.8%), from €68,333 to €24,711
- Staff costs -€26,449
down €26,449 (-56.5%), from €46,812 to €20,362
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €43,942 | €56,826 | +€12,884 | +29.3% |
| Current assets | 29/58 | €43,942 | €56,826 | +€12,884 | +29.3% |
| Stocks and contracts in progress | 3 | - | €22,485 | +€22,485 | |
| Stocks | 30/36 | - | €22,485 | +€22,485 | |
| Amounts receivable within one year | 40/41 | - | €33,950 | +€33,950 | |
| Trade receivables | 40 | - | €23,950 | +€23,950 | |
| Other amounts receivable | 41 | - | €10,000 | +€10,000 | |
| Cash at bank and in hand | 54/58 | €43,942 | €391 | -€43,551 | -99.1% |
| Total equity and liabilities | 10/49 | €43,942 | €56,826 | +€12,884 | +29.3% |
| Equity | 10/15 | €20,928 | €24,799 | +€3,871 | +18.5% |
| Profit (loss) carried forward | 14 | €20,928 | €24,799 | +€3,871 | +18.5% |
| Amounts payable | 17/49 | €23,014 | €32,027 | +€9,013 | +39.2% |
| Amounts payable within one year | 42/48 | €23,014 | €32,027 | +€9,013 | +39.2% |
| Trade debts | 44 | €4,205 | - | -€4,205 | |
| Suppliers | 440/4 | €4,205 | - | -€4,205 | |
| Advances received on contracts in progress | 46 | - | €4,779 | +€4,779 | |
| Taxes, remuneration and social security | 45 | €18,809 | €24,621 | +€5,813 | +30.9% |
| Taxes | 450/3 | €14,841 | €19,010 | +€4,169 | +28.1% |
| Remuneration and social security | 454/9 | €3,968 | €5,611 | +€1,644 | +41.4% |
| Other amounts payable | 47/48 | - | €2,627 | +€2,627 | |
| Remuneration, social security and pensions | 62 | €46,812 | €20,362 | -€26,449 | -56.5% |
| Other operating charges | 640/8 | €329 | €238 | -€91 | -27.7% |
| Gross operating margin | 9900 | €68,333 | €24,711 | -€43,623 | -63.8% |
| Operating profit (loss) | 9901 | €21,193 | €4,111 | -€17,082 | -80.6% |
| Financial charges | 65/66B | €265 | €240 | -€25 | -9.4% |
| Recurring financial charges | 65 | €265 | €240 | -€25 | -9.4% |
| Profit (loss) for the period before taxes | 9903 | €20,928 | €3,871 | -€17,057 | -81.5% |
| Profit (loss) for the period | 9904 | €20,928 | €3,871 | -€17,057 | -81.5% |
| Profit (loss) for the period to be appropriated | 9905 | €20,928 | €3,871 | -€17,057 | -81.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.